Results 201 to 210 of about 996,158 (312)

Reassessment-stage metabolic indices and subsequent cardiorenal outcomes in adults with diabetes: CHARLS and an independent hospital validation cohort. [PDF]

Front Endocrinol (Lausanne)
Liu M, Kong Y, Chen S, Wu S, Sun B, Chen L.   +5 more
europepmc   +1 more source

In Silico Clinical Trials in Drug Development: Virtual Patients, Applications, and Regulatory Convergence

Clinical Pharmacology &Therapeutics, EarlyView.
Conventional clinical trials remain the benchmark for evaluating therapeutic safety and efficacy, yet they are constrained by escalating costs, withdrawal over the extended follow‐up periods, recruitment difficulties, ethical limits, and a restricted ability to characterize heterogeneous populations.
Maximilian Balmus, Sheng‐Ya Wang, Edward W. G. Ashton, Rosie K. Barrows, Molly Monks, Yuzhang Ge, Arthur Lefebvre, Steven A. Niederer   +7 more
wiley   +1 more source

Factors affecting patients' trust in physicians in the cases of prescribing invasive interventions among musculoskeletal patients referring to clinics in Shiraz, 2023: a discrete choice experiment. [PDF]

Sci Rep
Javanmardi A, Delavari S, Kavosi Z, Tavakolian A, Bayati M.   +4 more
europepmc   +1 more source

Considerations for the Integration of Clinical Trials and Real‐World Data

Clinical Pharmacology &Therapeutics, EarlyView.
As clinical decision‐making increasingly moves toward individualized and context‐specific treatment recommendations, reliance on any single evidence source, randomized or observational, may be insufficient. Principled integration of randomized controlled trials and real‐world data, grounded in explicit causal frameworks, offers a path toward evidence ...
Sky Qiu, Charles E. Barr, Lauren Dang, Larry Han, Kajsa Kvist, Hana Lee, Andrew Mertens, Nerissa Nance, Lei Nie, Kara Rudolph, Xu Shi, Jens Tarp, Salina P. Waddy, Kenneth Wiley, Andy Wilson, Margot Lisa Jing Yann, Zhiwei Zhang, Tianyue Zhou, Maya Petersen, Mark van der Laan   +19 more
wiley   +1 more source

What drives family physicians to rural practice? A discrete choice experiment in Vietnam. [PDF]

Health Policy Open
Pham CAT, Le NQT, Kim D.
europepmc   +1 more source

Seats at the Table, Shifts in the Actions: Board Gender Diversity and Climate Activism

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT As regulatory and stakeholder pressures intensify, firms are increasingly expected to move beyond symbolic sustainability commitments towards corporate climate activism. This concept refers to the active institutionalisation of climate‐focused mechanisms such as external assurance, board oversight and climate‐linked incentives.
Md Tanvir Hamim, Rasim Simsek
wiley   +1 more source

A prospective descriptive cohort study of women aged ≥40 years conceiving through IVF at a tertiary care center. [PDF]

Front Reprod Health
Domínguez-Moreno M, Walsh B, De-Martín-Hernández J, Chimenea Á, Antiñolo G, García-Díaz L.   +5 more
europepmc   +1 more source

The Price of Circularity: Exploring the Determinants of Consumer Willingness to Pay

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The transition towards a circular economy (CE) requires not only technological and organisational innovation but also consumer engagement in adopting circular products. A key driver of this process is consumers' stated willingness to pay (WTP) a premium, which remains constrained by psychological, perceptual and contextual barriers.
Valerio Muto, Vincenzo Basile, Nunzia Petacca, Anna Prisco   +3 more
wiley   +1 more source

Patient preferences for managing chronic breast cancer-related lymphedema in China: evidence from a discrete choice experiment. [PDF]

BMC Health Serv Res
Gao L, Gao Y, Liu T, Yu J, Han J, Liu S, Wang R, Ming WK, Guo J.   +8 more
europepmc   +1 more source

Discrete uniform subgroups of lie groups

Topology, 1970
openaire   +1 more source